| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Elisa J Sob. Cultural conformity and cannabis care in the wake of intractable pediatric epilepsy. Anthropology & medicine. vol 28. issue 2. 2021-08-19. PMID:34075822. |
using data from 25 californian (us) parents who favored providing cannabis to their ill children to meet the iatrogenic burdens of biomedical epilepsy treatments in 2015, well before cannabis's present destigmatization, this paper explores parental refiguration of the effects of clinical iatrogenesis as inevitable - and as productive of evidence necessary to finding better options. |
2021-08-19 |
2023-08-13 |
Not clear |
| Alain Lekoubou, Jonah Fox, Kinfe G Bishu, Bruce Ovbiagel. Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States. Epilepsy research. vol 163. 2021-08-18. PMID:32361206. |
trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the united states. |
2021-08-18 |
2023-08-13 |
Not clear |
| Alain Lekoubou, Jonah Fox, Kinfe G Bishu, Bruce Ovbiagel. Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States. Epilepsy research. vol 163. 2021-08-18. PMID:32361206. |
given ongoing contemporary societal controversies about medicinal and recreational cannabis use, we aimed to ascertain recent nationwide prevalence, trends, and psychiatric diagnoses associated with cannabis use disorders (cud) among epilepsy patients. |
2021-08-18 |
2023-08-13 |
Not clear |
| Monica Zilmer, Kern Olofsso. Cannabidiol treatment of severe refractory epilepsy in children and young adults. Danish medical journal. vol 68. issue 5. 2021-08-18. PMID:33913416. |
cannabidiol treatment of severe refractory epilepsy in children and young adults. |
2021-08-18 |
2023-08-13 |
Not clear |
| Monica Zilmer, Kern Olofsso. Cannabidiol treatment of severe refractory epilepsy in children and young adults. Danish medical journal. vol 68. issue 5. 2021-08-18. PMID:33913416. |
since 2016, the paediatric department of the filadelfia epilepsy hospital, denmark, has been treating patients with cannabidiol for severe refractory epilepsy. |
2021-08-18 |
2023-08-13 |
Not clear |
| Hagar Cohen, Uri Kramer, Moran Hausman-Kedem, Shimrit Uliel-Siboni, Sara Eya. Dosage of cannabidiol-enriched cannabis in children and adults with epilepsy. Brain & development. vol 43. issue 8. 2021-08-17. PMID:34226095. |
dosage of cannabidiol-enriched cannabis in children and adults with epilepsy. |
2021-08-17 |
2023-08-13 |
Not clear |
| Simona Lattanzi, Eugen Trinka, Pasquale Striano, Chiara Rocchi, Sergio Salvemini, Mauro Silvestrini, Francesco Brig. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. CNS drugs. vol 35. issue 3. 2021-08-09. PMID:33754312. |
highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond dravet syndrome and lennox-gastaut syndrome. |
2021-08-09 |
2023-08-13 |
Not clear |
| Marissa Gibbard, Dawn Mount, Shahrad R Rassekh, Harold Hal Side. Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study. CMAJ open. vol 9. issue 2. 2021-08-06. PMID:34021014. |
family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study. |
2021-08-06 |
2023-08-13 |
Not clear |
| Elinor Ben-Menachem, Boudewijn Gunning, Carmen María Arenas Cabrera, Kevan VanLandingham, Julie Crockett, David Critchley, Louise Wray, Bola Tayo, Gilmour Morrison, Manuel Toled. A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy. CNS drugs. vol 34. issue 6. 2021-08-05. PMID:32350749. |
a phase ii randomized trial to explore the potential for pharmacokinetic drug-drug interactions with stiripentol or valproate when combined with cannabidiol in patients with epilepsy. |
2021-08-05 |
2023-08-13 |
Not clear |
| Kevan E VanLandingham, Julie Crockett, Lesley Taylor, Gilmour Morriso. A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam. Journal of clinical pharmacology. vol 60. issue 10. 2021-07-30. PMID:32652616. |
we investigated the effects of cannabidiol (cbd; 21-day maintenance dose) on the pharmacokinetics (pk) of clobazam (clb) and monitored the safety of cbd (or placebo) plus clb in 20 patients with uncontrolled epilepsy on stable doses of clb. |
2021-07-30 |
2023-08-13 |
Not clear |
| Randi von Wrede, Susanna Moskau-Hartmann, Nicola Amarell, Rainer Surges, Christian Erich Elger, Christoph Helmstaedte. Plant derived versus synthetic cannabidiol: Wishes and commitment of epilepsy patients. Seizure. vol 80. 2021-07-28. PMID:32554292. |
plant derived versus synthetic cannabidiol: wishes and commitment of epilepsy patients. |
2021-07-28 |
2023-08-13 |
Not clear |
| Randi von Wrede, Susanna Moskau-Hartmann, Nicola Amarell, Rainer Surges, Christian Erich Elger, Christoph Helmstaedte. Plant derived versus synthetic cannabidiol: Wishes and commitment of epilepsy patients. Seizure. vol 80. 2021-07-28. PMID:32554292. |
a special component of cannabis, cannabidiol (cbd), is currently in the focus of epilepsy treatment and research. |
2021-07-28 |
2023-08-13 |
Not clear |
| b' Sara Malaca, Massimo Gottardi, Federica Pigliasco, Sebastiano Barco, Alessia Cafaro, Elisabetta Amadori, Antonella Riva, Martina Marcenaro, Pasquale Striano, Giuliana Cangemi, Roberta Pacifici, Simona Pichini, Francesco Paolo Busard\\xc3\\xb. UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations. Pharmaceuticals (Basel, Switzerland). vol 14. issue 7. 2021-07-27. PMID:34209666.' |
uhplc-ms/ms analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with cbd formulations. |
2021-07-27 |
2023-08-13 |
Not clear |
| Ernesto Gonzalez-Giraldo, Joseph E Sulliva. Advances in the Treatment of Drug-Resistant Pediatric Epilepsy. Seminars in neurology. vol 40. issue 2. 2021-07-26. PMID:32185791. |
recent publications have shown the efficacy of new pharmaceutical options such as fenfluramine and cannabidiol, some of which have been tested specifically in patients with childhood-onset epilepsy syndromes such as dravet's syndrome and lennox-gastaut's syndrome. |
2021-07-26 |
2023-08-13 |
Not clear |
| Stephanie M DeGasperis, Richard Webster, Daniela Poh. Cannabis Treatment in Children with Epilepsy: Practices of Canadian Neurologists. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 47. issue 4. 2021-07-13. PMID:32127067. |
cannabis treatment in children with epilepsy: practices of canadian neurologists. |
2021-07-13 |
2023-08-13 |
Not clear |
| Stephanie M DeGasperis, Richard Webster, Daniela Poh. Cannabis Treatment in Children with Epilepsy: Practices of Canadian Neurologists. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 47. issue 4. 2021-07-13. PMID:32127067. |
medical cannabis has recently emerged as a treatment option for children with drug-resistant epilepsy. |
2021-07-13 |
2023-08-13 |
Not clear |
| Stephanie M DeGasperis, Richard Webster, Daniela Poh. Cannabis Treatment in Children with Epilepsy: Practices of Canadian Neurologists. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 47. issue 4. 2021-07-13. PMID:32127067. |
despite the fact that many pediatric epilepsy patients across canada are currently being treated with cannabis, little is known about the attitudes of neurologists toward cannabinoid treatment of children with epilepsy. |
2021-07-13 |
2023-08-13 |
Not clear |
| Christopher G S Gilmartin, Zoya Dowd, Alasdair P J Parker, Pooja Harija. Interaction of cannabidiol with other antiseizure medications: A narrative review. Seizure. vol 86. 2021-07-12. PMID:33541771. |
cannabidiol is efficacious as an adjunctive treatment in children with epilepsy associated with dravet and lennox-gastaut syndromes. |
2021-07-12 |
2023-08-13 |
Not clear |
| Joseph L Damstra-Oddy, Eleanor C Warren, Christopher J Perry, Yann Desfougères, John-Mark K Fitzpatrick, Judith Schaf, Lisa Costelloe, William Hind, Eric J Downer, Adolfo Saiardi, Robin S B William. Phytocannabinoid-dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity. British journal of pharmacology. vol 178. issue 5. 2021-07-05. PMID:33347604. |
cannabidiol (cbd) has been shown to differentially regulate the mechanistic target of rapamycin complex 1 (mtorc1) in preclinical models of disease, where it reduces activity in models of epilepsies and cancer and increases it in models of multiple sclerosis (ms) and psychosis. |
2021-07-05 |
2023-08-13 |
Not clear |
| Willian Lazarini-Lopes, Raquel A Do Val-da Silva, Rui M P da Silva-Júnior, Gleice K Silva-Cardoso, Christie R A Leite-Panissi, João P Leite, Norberto Garcia-Cairasc. Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy. Epilepsy & behavior : E&B. vol 119. 2021-06-29. PMID:33887676. |
chronic cannabidiol (cbd) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy. |
2021-06-29 |
2023-08-13 |
rat |